Argenx NV ADR (ARGX) has had the highest return between November 8, 2015 and November 8, 2025 by a US stock in the Biotechnology Industry with a market cap of $10B+, returning 4,674.6%.
| ASSET | DATE | % RETURN |
|---|---|---|
argenx NV ADR (ARGX) | 11/8/2015 - 11/8/2025 | 4,674.58% |
Natera (NTRA) | 11/8/2015 - 11/8/2025 | 2,085.87% |
Madrigal Pharmaceuticals (MDGL) | 11/8/2015 - 11/8/2025 | 2,050.59% |
Insmed (INSM) | 11/8/2015 - 11/8/2025 | 1,046.92% |
Ascendis Pharma A-S (ASND) | 11/8/2015 - 11/8/2025 | 1,012.15% |
BeiGene (ONC) | 11/8/2015 - 11/8/2025 | 1,004.49% |
EXACT Sciences (EXAS) | 11/8/2015 - 11/8/2025 | 585.09% |
Exelixis (EXEL) | 11/8/2015 - 11/8/2025 | 552.96% |
BioNTech SE (BNTX) | 11/8/2015 - 11/8/2025 | 525.09% |
AbbVie (ABBV) | 11/8/2015 - 11/8/2025 | 422.14% |
Alnylam Pharmaceuticals (ALNY) | 11/8/2015 - 11/8/2025 | 342.92% |
Vertex Pharmaceuticals (VRTX) | 11/8/2015 - 11/8/2025 | 247.89% |
United Therapeutics (UTHR) | 11/8/2015 - 11/8/2025 | 192.26% |
Neurocrine Biosciences (NBIX) | 11/8/2015 - 11/8/2025 | 184.54% |
Genmab A-S (GMAB) | 11/8/2015 - 11/8/2025 | 178.79% |
Amgen (AMGN) | 11/8/2015 - 11/8/2025 | 169.25% |
Avidity Biosciences (RNA) | 11/8/2015 - 11/8/2025 | 163.55% |
Revolution Medicines (RVMD) | 11/8/2015 - 11/8/2025 | 116.27% |
BridgeBio Pharma (BBIO) | 11/8/2015 - 11/8/2025 | 101.89% |
Summit Therapeutics (SMMT) | 11/8/2015 - 11/8/2025 | 99.78% |
Roivant Sciences (ROIV) | 11/8/2015 - 11/8/2025 | 96.38% |
Gilead Sciences (GILD) | 11/8/2015 - 11/8/2025 | 56.16% |
Ionis Pharmaceuticals (IONS) | 11/8/2015 - 11/8/2025 | 36.28% |
Haleon (HLN) | 11/8/2015 - 11/8/2025 | 27.35% |
Regeneron Pharmaceuticals (REGN) | 11/8/2015 - 11/8/2025 | 17.74% |
